Sharp and the WHO Global Health Workforce Alliance National Center of Tuberculosis and Lung Disease put together a team of experts to test and study the power of the Plasmacluster Ion Technology in preventing the spread and infection of Tuberculosis.
For both groups, the experiment came in with favorable results. The Plasmacluster Ion Technology reduced the risk of healthcare workers to carry the Tuberculosis bacteria. Only 1 out of 10 workers in the PCI-protected area tested as a positive carrier. The rooms without PCI resulted to 6 out of 15 positive carriers.
Results for ADR-positive patients decreased as well. The Plasmacluster Ion Technology-equipped room only generated 1 out of 25 patients. The rooms without the devices resulted to 4 out of 19 affected patients.
These results only prove that the Plasmacluster Ion Technology truly helps decrease the spread of Tuberculosis and aid culture positive patients in repressing ADR. These impressive findings paved the way for the researchers to secure an invitation to the 21st Congress of Asian Pacific Society of Respirology.
References:
George Schiffman, F. (2016). Tuberculosis Causes, Symptoms, Treatment - What Are Causes of Tuberculosis? - eMedicineHealth. eMedicineHealth. Retrieved 10 October 2016, from http://www.emedicinehealth.com/tuberculosis/page2_em.htm
Sharp Corporation.,Plasmacluster Technology Proven to Decrease Risk of Tuberculosis Infection in Tuberculosis Hospital for the First Time. 2016. Print.
Tuberculosis (TB). (2016). World Health Organization. Retrieved 10 October 2016, from http://www.who.int/mediacentre/factsheets/fs104/en/
World Vision Philippines. N.p., 2016. Web. 15 Sept. 2016.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น